Mimedx GS-5230 Dehydrated Human Amnion Chorion Membrane Allograft 6sq cm
Mimedx GS-5230 Dehydrated Human Amnion Chorion Membrane Allograft 6sq cm
- Size: 2x3 cm (Mimedx GS-5230)
- 6sq cm
- 2cm x 3cm SheetÂ
Mimedx GS-5230
The GS‑5230 is an allograft sheet of EPIFIX® a dehydrated human amnion/chorion membrane (dHACM) measuring 2 cm × 3 cm, covering a total of 6 cm². EPIFIX is created through Mimedx’s proprietary PURION® processing method, which preserves a rich extracellular matrix structure along with over 300 regulatory proteins such as growth factors and cytokines. This minimally manipulated, non-viable tissue is terminally sterilized and shelf-stable for up to five years, offering a reliable, ready-to-use option in clinical settings.
The compact 6 cm² size of the GS‑5230 makes it particularly suited for managing small to medium-sized wounds with precision and efficiency. Its semi-permeable structure allows beneficial interaction with the wound bed while maintaining an optimal healing environment. Additionally, EPIFIX’s compatibility with adjunctive therapies such as negative-pressure wound therapy and compression or hyperbaric oxygen enhances its versatility. With strong clinical evidence, regulatory compliance (terminal sterilization, PURION® processing), and convenient packaging, GS‑5230 stands as a trusted choice for clinicians seeking effective regenerative healing solutions.
Understanding Mimedx GS-5230 Allograft
Mimedx GS-5230 Dehydrated Human Amnion Chorion Membrane Allograft is a revolutionary product in the field of regenerative medicine. This allograft is primarily derived from donated human tissue, ensuring the highest standards of safety and effectiveness. The unique properties of the dehydrated membrane contribute to enhanced healing in various medical applications, including surgical and wound care. Therefore, medical professionals have increasingly opted for Mimedx when addressing difficult-to-heal wounds.
Applications of Mimedx Membrane
The Mimedx GS-5230 allograft serves multiple purposes in clinical settings. It is particularly effective in the treatment of chronic wounds, burns, and post-surgical recovery. Because the dehydrated membrane provides a natural barrier against infection, it can help reduce complications during the healing process. So, healthcare providers can trust Mimedx to support optimal outcomes in tougher cases.
Benefits of Using Mimedx
One of the standout features of Mimedx GS-5230 is its ability to promote cell migration and tissue regeneration. As the membrane is rehydrated in the body, it releases essential growth factors that aid in the healing process. Additionally, patients often experience less scarring and shorter recovery times, because of the unique composition of the allograft. This positions Mimedx as a superior choice in regenerative therapies.
Mimedx GS-5230 Dehydrated Human Amnion Chorion Membrane Allograft 6sq cm
- Size: 2x3 cm (Mimedx GS-5230)
- 6sq cm
- 2cm x 3cm SheetÂ
Mimedx GS-5230
The GS‑5230 is an allograft sheet of EPIFIX® a dehydrated human amnion/chorion membrane (dHACM) measuring 2 cm × 3 cm, covering a total of 6 cm². EPIFIX is created through Mimedx’s proprietary PURION® processing method, which preserves a rich extracellular matrix structure along with over 300 regulatory proteins such as growth factors and cytokines. This minimally manipulated, non-viable tissue is terminally sterilized and shelf-stable for up to five years, offering a reliable, ready-to-use option in clinical settings.
The compact 6 cm² size of the GS‑5230 makes it particularly suited for managing small to medium-sized wounds with precision and efficiency. Its semi-permeable structure allows beneficial interaction with the wound bed while maintaining an optimal healing environment. Additionally, EPIFIX’s compatibility with adjunctive therapies such as negative-pressure wound therapy and compression or hyperbaric oxygen enhances its versatility. With strong clinical evidence, regulatory compliance (terminal sterilization, PURION® processing), and convenient packaging, GS‑5230 stands as a trusted choice for clinicians seeking effective regenerative healing solutions.
Understanding Mimedx GS-5230 Allograft
Mimedx GS-5230 Dehydrated Human Amnion Chorion Membrane Allograft is a revolutionary product in the field of regenerative medicine. This allograft is primarily derived from donated human tissue, ensuring the highest standards of safety and effectiveness. The unique properties of the dehydrated membrane contribute to enhanced healing in various medical applications, including surgical and wound care. Therefore, medical professionals have increasingly opted for Mimedx when addressing difficult-to-heal wounds.
Applications of Mimedx Membrane
The Mimedx GS-5230 allograft serves multiple purposes in clinical settings. It is particularly effective in the treatment of chronic wounds, burns, and post-surgical recovery. Because the dehydrated membrane provides a natural barrier against infection, it can help reduce complications during the healing process. So, healthcare providers can trust Mimedx to support optimal outcomes in tougher cases.
Benefits of Using Mimedx
One of the standout features of Mimedx GS-5230 is its ability to promote cell migration and tissue regeneration. As the membrane is rehydrated in the body, it releases essential growth factors that aid in the healing process. Additionally, patients often experience less scarring and shorter recovery times, because of the unique composition of the allograft. This positions Mimedx as a superior choice in regenerative therapies.
Description
Mimedx GS-5230 Dehydrated Human Amnion Chorion Membrane Allograft 6sq cm
- Size: 2x3 cm (Mimedx GS-5230)
- 6sq cm
- 2cm x 3cm SheetÂ
Mimedx GS-5230
The GS‑5230 is an allograft sheet of EPIFIX® a dehydrated human amnion/chorion membrane (dHACM) measuring 2 cm × 3 cm, covering a total of 6 cm². EPIFIX is created through Mimedx’s proprietary PURION® processing method, which preserves a rich extracellular matrix structure along with over 300 regulatory proteins such as growth factors and cytokines. This minimally manipulated, non-viable tissue is terminally sterilized and shelf-stable for up to five years, offering a reliable, ready-to-use option in clinical settings.
The compact 6 cm² size of the GS‑5230 makes it particularly suited for managing small to medium-sized wounds with precision and efficiency. Its semi-permeable structure allows beneficial interaction with the wound bed while maintaining an optimal healing environment. Additionally, EPIFIX’s compatibility with adjunctive therapies such as negative-pressure wound therapy and compression or hyperbaric oxygen enhances its versatility. With strong clinical evidence, regulatory compliance (terminal sterilization, PURION® processing), and convenient packaging, GS‑5230 stands as a trusted choice for clinicians seeking effective regenerative healing solutions.
Understanding Mimedx GS-5230 Allograft
Mimedx GS-5230 Dehydrated Human Amnion Chorion Membrane Allograft is a revolutionary product in the field of regenerative medicine. This allograft is primarily derived from donated human tissue, ensuring the highest standards of safety and effectiveness. The unique properties of the dehydrated membrane contribute to enhanced healing in various medical applications, including surgical and wound care. Therefore, medical professionals have increasingly opted for Mimedx when addressing difficult-to-heal wounds.
Applications of Mimedx Membrane
The Mimedx GS-5230 allograft serves multiple purposes in clinical settings. It is particularly effective in the treatment of chronic wounds, burns, and post-surgical recovery. Because the dehydrated membrane provides a natural barrier against infection, it can help reduce complications during the healing process. So, healthcare providers can trust Mimedx to support optimal outcomes in tougher cases.
Benefits of Using Mimedx
One of the standout features of Mimedx GS-5230 is its ability to promote cell migration and tissue regeneration. As the membrane is rehydrated in the body, it releases essential growth factors that aid in the healing process. Additionally, patients often experience less scarring and shorter recovery times, because of the unique composition of the allograft. This positions Mimedx as a superior choice in regenerative therapies.
